Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12134631
Hydrophilic linkers for antibody drug conjugates
granted -
US 12127536
Humanized M-CSF mice
granted -
US 12123001
Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors
granted -
US 12116622
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
granted -
US 12115216
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
granted -
US 12110502
Models of tauopathy
granted -
US 12103960
VEGF traps and mini-traps and methods for treating ocular disorders and cancer
granted -
US 12096754
Non-human animals having a humanized lymphocyte-activation gene 3
granted -
US 12090193
Glucagon-like peptide 1 receptor agonists and uses thereof
granted -
US 12091449
Anti-PfRH5 antibodies and antigen-binding fragments thereof
granted -
US 12090201
Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody
granted -
US 12091460
Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation
granted -
US 12089575
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
granted -
US 12091440
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
granted -
US 12084516
Anti-C5 antibody combinations and uses thereof
granted -
US 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted -
US 12082566
Rodent animals expressing human CR1
granted -
US 12082565
Non-human animals models of retinoschisis
granted -
US 12077570
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12077587
Anti-CD8 antibodies and uses thereof
granted -
US 12077782
Viral clearance by low pH hold
granted -
US 12077593
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 12070502
Process for reducing subvisible particles in a pharmaceutical formulation
granted -
US 12070460
Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors
granted